mRNA |
OSI-906 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-07 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
4e-06 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-06 |
mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
2e-05 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-05 |
mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
0.0002 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0004 |